A new publication about incorporating Spinal Muscular Atrophy (SMA) in newborn screening programs across Europe is now available in the Rare Disease and Orphan Drugs Journal. The paper highlights how patient advocacy organizations represent a key partner in ensuring equitable and early diagnosis.
📖 Read the full publication here: https://lnkd.in/emYepUDX
📚 More publications on Newborn Screening: https://lnkd.in/eaBmFg_D